Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma

Cancer Treatment Reviews

Volumn 31, Issue 7, 2005, Pages 577-581

  Brandes, Alba A ^a  

^a Neuro Oncology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG ERUPTION; FATIGUE; GLIOBLASTOMA; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUTROPENIA; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; THROMBOCYTOPENIA; VISUAL DISORDER;

EID: 27744501693     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2005.08.004     Document Type: Note

References (6)

1. A. Jemal T. Murray E. Ward et al. Cancer statistics, 2005 CA Cancer J Clin 55 2005 1030
2. B.J. McCarthy C. Kruchko Consensus conference on cancer registration of brain and central nervous system tumors Neuro-oncology 7 2005 196201
3. A.A. Brandes State-of-the-art treatment of high-grade brain tumors Semin Oncol 30 Suppl. 19 2003 49
4. S. Lonardi A. Tosoni A.A. Brandes Adjuvant chemotherapy in the treatment of high grade gliomas Cancer Treat Rev 31 2005 7989
5. R. Stupp W.P. Mason M.J. van den et al. Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 98796
6. M.E. Hegi A.C. Diserens T. Gorlia et al. MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 9971003